ABBV AbbVie Inc.
Research report · from SEC EDGAR · close 2026-07-10
$248.08 -0.7%
$438.31B mkt cap
executive summary
AbbVie Inc. (ABBV) is a $438.31B company. Revenue is $62.82B (+9.5% y/y) at a 6% net margin. It is profitable. Our health score is C (69/100). No major red flags on file. It funds itself; low dilution risk.
Revenue (TTM)
$62.82B
+9.5% y/y
✓ No major red flags from our filing-based checks.
who's buying
Insider buys / sells
0 / 2
Cash & ST investments
$9.39B
Operating cash flow
$19.03B
Dilution shelf
active shelf
FILINGResults announced
8-K filed 2026-07-06
Assembled from SEC EDGAR (XBRL, Form 4, 13F, filings), STOCK Act disclosures, and end-of-day prices — every figure is real and sourced; nothing is fabricated or predicted. Filings lag 40–90 days. Educational, not investment advice. Generated 2026-07-10 by stocktools.ai.